GLP-1 (7-36) amide: Effects on glucose transport and metabolism in rat adipose tissue
The DOI matches its Crossref record.
Abstract
In rat adipocytes, GLP-1 (7-36) amide induced an increment in 2-deoxy-glucose uptake, which was additive to that of insulin. Furthermore, in rat fat, GLP-1 (7-36) amide provoked a rise in glycogen synthesis, glucose oxidation and utilization and lipogenesis, the increments being lower than those obtained with insulin. These data support the idea that GLP-1 exerts insulin-like effects on glucose metabolism in rat adipose tissue, as it does in rat hepatocytes and skeletal muscle, although with a lower potency than that of insulin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to experimental research, GLP-1 can certainly cause both lipogenic and lipolytic effects in a dose-dependent manner, with lipogenic action predominating at picomolar concentrations and lipolytic action at nanomolar doses [59,60,61,62,63].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [60]
Citations
Cites
Still being checked.
Cited by
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
Armstrong, M. J., Hull, D., Guo, K., Barton, D., Hazlehurst, J. M., Gathercole, L. L., Nasiri, M., Yu, J., Gough, S. C., Newsome, P. N., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.038 · Cited by 456
“05) and alanine transaminase (ALT) (90 [36,137] vs.”
Vendrell, J., El Bekay, R., Peral, B., García-Fuentes, E., Megia, A., Macias-Gonzalez, M., Real, J. F., Jimenez-Gomez, Y., Escoté, X., Pachón, G., et al. (2011) · Endocrinology · doi:10.1210/en.2011-1070 · Cited by 173
Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
Luque, M., Gonzalez, N., Marquez, L., Acitores, A., Redondo, A., Morales, M., Valverde, I., & Villanueva-Penacarrillo, M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730465 · Cited by 131
Self-citationGlucagon-like peptide-1: a major regulator of pancreatic beta-cell function
Perfetti, R., & Merkel, P. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430717 · Cited by 143
Deacon, C. F., Plamboeck, A., Møller, S., & Holst, J. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00452.2001 · Cited by 103
Cell signalling of the GLP-1 action in rat liver
Redondo, A., Trigo, M. V., Acitores, A., Valverde, I., & Villanueva-Peñacarrillo, M. L. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00146-1 · Cited by 108
Self-citationEffect of GLP-1 Treatment on GLUT2 and GLUT4 Expression in Type 1 and Type 2 Rat Diabetic Models
Villanueva‐Peñacarrillo, M. L., Puente, J., Redondo, A., Clemente, F., & Valverde, I. (2001) · Endocrine · doi:10.1385/endo:15:2:241 · Cited by 104
Self-citationEffect of GLP-1 on glucose transport and its cell signalling in human myocytes
González, N., Acitores, A., Sancho, V., Valverde, I., & Villanueva-Peñacarrillo, M. L. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.10.002 · Cited by 85
Self-citationRibel, U., Larsen, M. O., Rolin, B., Carr, R. D., Wilken, M., Sturis, J., Westergaard, L., Deacon, C. F., & Knudsen, L. B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02189-1 · Cited by 84
Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes
El Bekay, R., Coín‐Aragüez, L., Fernández‐García, D., Oliva‐Olivera, W., Bernal‐López, R., Clemente‐Postigo, M., Delgado‐Lista, J., Diaz‐Ruiz, A., Guzman‐Ruiz, R., Vázquez‐Martínez, R., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13481 · Cited by 78
Sancho, V., Trigo, M. V., González, N., Valverde, I., Malaisse, W. J., & Villanueva-Peñacarrillo, M. L. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01747 · Cited by 78
Self-citationBifari, F., Manfrini, R., Dei Cas, M., Berra, C., Siano, M., Zuin, M., Paroni, R., & Folli, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.025 · Cited by 69
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options
De Caterina, R., Madonna, R., Sourij, H., & Wascher, T. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq162 · Cited by 69
de Carvalho, C. P., Marin, D. M., de Souza, A. L., Pareja, J. C., Chaim, É. A., de Barros-Mazon, S., da Silva, C. A., Geloneze, B., Muscelli, E., & Alegre, S. M. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9678-5 · Cited by 64
Effect of GLP-1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects
Sancho, V., Trigo, M., Martín-Duce, A., González, N., Acitores, A., Arnés, L., Valverde, I., Malaisse, W., & Villanueva-Peñacarrillo, M. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.6.1133 · Cited by 53
Self-citationWeiss, E. P., Albert, S. G., Reeds, D. N., Kress, K. S., Ezekiel, U. R., McDaniel, J. L., Patterson, B. W., Klein, S., & Villareal, D. T. (2015) · Diabetes Care · doi:10.2337/dc14-2913 · Cited by 63
Glucosensing in the gastrointestinal tract: Impact on glucose metabolism
Fournel, A., Marlin, A., Abot, A., Pasquio, C., Cirillo, C., Cani, P. D., & Knauf, C. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00015.2016 · Cited by 62
Åhrén, B., & Pacini, G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e996 · Cited by 60
A Glucagon-Like Peptide-1 Receptor Agonist and an Antagonist Modify Macronutrient Selection by Rats
Peters, C. T., Choi, Y.-H., Brubaker, P. L., & Anderson, G. H. (2001) · Journal of Nutrition · doi:10.1093/jn/131.8.2164 · Cited by 60
Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle
Acitores, A., Gonzalez, N., Sancho, V, Valverde, I., & Villanueva-Penacarrillo, M. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1800389 · Cited by 55
Self-citationEjarque, M., Guerrero-Pérez, F., de la Morena, N., Casajoana, A., Virgili, N., López-Urdiales, R., Maymó-Masip, E., Pujol Gebelli, J., Garcia Ruiz de Gordejuela, A., Perez-Maraver, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42770-1 · Cited by 53
Huisamen, B., Genade, S., & Lochner, A. (2008) · Europe PMC (PubMed Central) · Cited by 53
López-Delgado, M. I., Morales, M., Villanueva-Peñacarrillo, M. L., Malaisse, W. J., & Valverde, I. (1998) · Endocrinology · doi:10.1210/endo.139.6.6045 · Cited by 42
Self-citationGLP-1: benefits beyond pancreas
Muscogiuri, G., Cignarelli, A., Giorgino, F., Prodram, F., Santi, D., Tirabassi, G., Balercia, G., Modica, R., Faggiano, A., & Colao, A. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0137-y · Cited by 42
Akarte, A. S., Srinivasan, B. P., & Gandhi, S. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.03.013 · Cited by 42
Márquez, L., Trapote, M. A., Luque, M. A., Valverde, I., & Villanueva-Peñacarrillo, M. L. (1998) · Cell Biochemistry and Function · doi:10.1002/(sici)1099-0844(199803)16:1<51::aid-cbf767>3.0.co;2-t · Cited by 34
Self-citationSancho, V., Nuche, B., Arnés, L., Cancelas, J., Gonz´lez, N., Díaz-Miguel, M., Martín-Duce, A., Valverde, I., & Villanueva-Peñacarrillo, M. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.6.961 · Cited by 40
Self-citationGreen, B., Gault, V., Mooney, M., Irwin, N., Bailey, C., Harriott, P., Greer, B., Flatt, P., & O'Harte, F. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310529 · Cited by 36
Puddu, A., Mach, F., Nencioni, A., Viviani, G. L., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/591056 · Cited by 35
Parthsarathy, V., Hogg, C., Flatt, P. R., & O'Harte, F. P. M. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13068 · Cited by 30
Moreno, P., Nuche‐Berenguer, B., Gutiérrez-Rojas, I., Acitores, A., Sancho, V., Valverde, I., González, N., & Villanueva‐Peñacarrillo, M. L. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0127 · Cited by 29
Self-citationAkarte, A. S., Srinivasan, B. P., Gandhi, S., & Sole, S. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.07.003 · Cited by 28
Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis
Cignarelli, A., Giorgino, F., & Vettor, R. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.796996 · Cited by 24
Pharmacological modulation of adaptive thermogenesis: new clues for obesity management?
Genchi, V. A., Palma, G., Sorice, G. P., D’Oria, R., Caccioppoli, C., Marrano, N., Biondi, G., Caruso, I., Cignarelli, A., Natalicchio, A., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02125-0 · Cited by 23
Moreno, P., Acitores, A., Gutiérrez-Rojas, I., Nuche‐Berenguer, B., Assar, M. E., Rodríguez‐Mañas, L., Gomis, R., Valverde, I., Visa, M., Malaisse, W. J., et al. (2011) · Peptides · doi:10.1016/j.peptides.2011.09.007 · Cited by 22
Self-citationCariou, B. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.04.003 · Cited by 19
Hansen, B. F., Jensen, P. B., Nepper-Christensen, E., & Skjølstrup, B. (1998) · Acta Diabetologica · doi:10.1007/s005920050112 · Cited by 19
De Fano, M., Malara, M., Vermigli, C., & Murdolo, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168650 · Cited by 17
Identification and characterization of adipose surface epitopes
Onogi, Y., Khalil, A., & Ussar, S. (2020) · Biochemical Journal · doi:10.1042/bcj20190462 · Cited by 16
Incretin attenuates diabetes-induced damage in rat cardiac tissue
Elbassuoni, E. (2014) · The Journal of Physiological Sciences · doi:10.1007/s12576-014-0327-6 · Cited by 12
Holz, G. G., & Leech, C. A. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1669-9_7 · Cited by 7
El GLP-1: acción biológica y posibles efectos terapéuticos
Valverde, I., Cancelas, J., & Villanueva-Peñacarrillo, M. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71100-7 · Cited by 8
Self-citationMoreno-Villegas, Z., Martín‐Duce, A., Aparicio, C., Portal‐Núñez, S., Sanz, R. L., Mantey, S. A., Jensen, R. T., Lorenzo, Ó., Egido, J., & González, N. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.01.028 · Cited by 5
Glucagon and Glucagon‐like Peptide Production and Degradation
Kieffer, T. J., Hussain, M. A., & Habener, J. F. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070208 · Cited by 5
Duparc, T. (2012) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III) · Cited by 4
Il controllo glicemico in unità coronarica: valore prognostico e nuove strategie terapeutiche
Madonna, R., Colella, M. E., & Caterina, R. D. (2008) · Giornale Ialiano di Cardiologia · doi:10.1714/632.7380 · Cited by 3
Glucagon-like peptide-1 and beta cell glucose sensitivity - a glucose ramp study in mice
Åhrén, B. (2021) · Peptides · doi:10.1016/j.peptides.2021.170650 · Cited by 2
Pérez, P. M. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Papel de la dieta en la secreción y acción del GLP-1 sobre la Homeostasis de la glucosa
Prieto, P. G. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Glucagon-like peptide-1 in nonalcoholic steatohepatitis
Armstrong, M. J. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Esteban, T., & Pilar, M. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
White, H. A. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0088663
Investigation into glucagon like peptide-1 signalling in pancreatic [beta}-cells
Moore, C. E. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Modulation of fat oxidation: nutritional and pharmacological approach
van Can, J. G. P. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121031jc
Metadata
- Authors
- Perea, A., Viñambres, C., Clemente, F., Villanueva-Peñacarrillo, M., & Valverde, I.
- Affiliations
- Hospital Universitario Fundación Jiménez Díaz (ES)
- ORCID
- Clemente, F.
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 1997-09
- Volume
- 29
- Issue
- 09
- Pages
- 417-421
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W2055264960
- Cited by
- 53
- References
- 0
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hormone and Metabolic Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Comunidad de Madrid
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- GLP-1(7-36)amide, adipose tissue, adipocytes, glucose transport, 2-deoxyglucose uptake, insulin-like activity, glycogen synthesis, glucose oxidation, lipogenesis, glucose metabolism, insulin potency
- MeSH terms
- Adipose Tissue, Animals, Biological Transport, Deoxyglucose, Glucagon-Like Peptides, Glucagon, Glucose, Glycogen, Insulin, Lipids, Male, Oxidation-Reduction, Peptide Fragments, Rats, Wistar, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.